(2S)-propane-1,2-diamine,dihydrochloride

We are (2S)-propane-1,2-diamine,dihydrochloride CAS:19777-66-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2S)-propane-1,2-diamine,dihydrochloride
CAS.NO:19777-66-3
Synonyms:(2S)-propane-1,2-diamine,dihydrochloride
(S)-(−)-Propylenediamine dihydrochloride
(S)-diaminopropane dihydrochloride
(S)-(-)-Diaminopropane Hydrochloride
S-(-)-1,2-diaminopropane dihydrochloride
R-(-)-1,2-propanediamine dihydrochloride
 
Physical and Chemical Properties:
Boiling Point 215.8ºC at 760 mmHg
Melting Point 227-229ºC
Molecular Formula C3H12Cl2N2
Molecular Weight 147.047
Flash Point 84.3ºC
 
Specification:
Appearance:Light yellow powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Dexrazoxane(CAS:24584-09-6) and Dexrazoxane hydrochloride(CAS:149003-01-0).

(2S)-propane-1,2-diamine,dihydrochloride


Related News: At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.4,4'-Dibromo-4''-phenyltriphenylamine Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.1-cloro-4- (clorometilsulfanil) benceno CAS:7205-90-5 The first is the API – which is the central ingredient.2-Amino-3-fluorobenzoic Acid The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.

Related Products
Product Name
2,4-Difluoropyridine View Details
gamma-Linolenic acid View Details
Diethanolamine View Details
N,6,6-trimethylhept-2-en-4-yn-1-amine manufacturer 2,4-Dichlorobenzotrifluoride manufacturer 5-Bromo-2-chlorobenzoic acid manufacturer Pyridoxine manufacturer 3-pyridinecarbonitrile manufacturer